# Acurable Limited

- Location (FDA's records): London, GB
- FDA decisions: 3 (2021–2025): 3 510(k) clearances
- Product codes: MNR (3)
- 510(k) review time since 2016: median 137 days, against 165 for FDA's reviews in the same codes and years (1 of 3 faster)
- Predicates its devices cite: 3 (2 its own); citations of its devices by later devices: 2 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Resonea, Inc.: 1 (https://510kreport.com/company/resonea)

## Its most-cited devices
- K222950: AcuPebble OX100 (2023), cited by 1
- K210480: AcuPebble SA (2021), cited by 1

## Recent decisions
- K243092: AcuPebble Ox (200) (Mar 19, 2025)
- K222950: AcuPebble OX100 (Feb 3, 2023)
- K210480: AcuPebble SA (Jul 6, 2021)

Source page: https://510kreport.com/company/acurable